Emerg Infect Dis by Lafolie, J\uc3\ua9r\uc3\ua9my et al.
4.28 × 109 cells/L, a hemoglobin level of 86 g/L, and a 
leukocyte count of 8.28 × 109 cells/L with 17% neutro-
phils and 78% lymphocytes.
The patient was given symptomatic supportive treat-
ment, methylprednisolone sodium succinate, and 5 g of 
γ-globulin. He was not given any antimicrobial drugs. On 
August 4, he was discharged from hospital after symptoms 
had resolved.
In conclusion, our results confirm that mimivirus is an 
unlikely cause of human respiratory infections in China, 
as reported in other countries (5–9). Sporadic detection of 
mimivirus in 1 child who was born with a compromised 
respiratory system and had numerous hospitalizations was 
most likely caused by colonization of the child with this 
virus during numerous hospitalizations and critical care 
stays. In addition, parainfluenza virus 3 and bocavirus were 
detected in the mimivirus-positive child. Because parain-
fluenza virus 3 causes pneumonia and bocavirus causes in-
fections with respiratory symptoms, particularly in children 
of his age, these 2 pathogens probably caused the illness in 
the child.
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To the Editor: Human adenoviruses (HAdVs) com-
prise 70 recognized genotypes (as of February 15, 2016; 
http://hadvwg.gmu.edu/) and are frequently associated 
with mild and acute upper respiratory tract infections, de-
pending on virus type and host immune status (1). HAdV 
type 55 (HAdV-55) has recently reemerged as a highly vir-
ulent pathogen, causing severe and sometimes fatal pneu-
monia among immunocompetent adults, particularly in 
Asia (2–4). Formerly known as HAdV-11a, HAdV-55 is a 
genotype resulting from recombination between HAdV-11 
and HAdV-14 (5). We report 2 cases of severe pneumonia 
associated with HAdV-55 infection in France.
In November 2014, two immunocompetent women, 
71 (patient A) and 36 (patient B) years of age, sought 
care 4 days apart at the emergency unit of the University 
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Hospital of Clermont-Ferrand, France, for an influenza-
like syndrome characterized by fever, cough, and dys-
pnea. Laboratory investigations at admission revealed 
thrombocytopenia (98 and 88 × 109 thrombocytes/L for 
patients A and B, respectively; reference range 150–450 × 
109 thrombocytes/L) and elevated C-reactive protein con-
centrations (71.6 and 45.8 mg/L, respectively; reference 
range <3 mg/L). Chest radiographs and thoracic tomoden-
sitometry images showed acute left lobar pneumonia in 
each patient. Therapy with intravenous antimicrobial 
drugs (cefepime and levofloxacin) and oxygen was initi-
ated. Patient A was transferred to the intensive care unit 
4 days after admission because of unimproved respiratory 
function; patient B was transferred 5 days after admission 
because of acute respiratory distress syndrome. 
Results for all bacteriologic analyses were negative 
(blood cultures, bronchoalveolar lavage fluid cultures, 
PCR for Mycobacterium tuberculosis [Xpert MTB/RIF; 
Cepheid, Sunnyvale, CA, USA] of bronchoalveolar lavage 
fluid, and urinary antigen testing [BinaxNOW Legionella 
and Streptococcus pneumoniae; Alere, Scarborough, ME, 
USA]). No specific antibodies were detected against Chla-
mydia pneumoniae (Anti-C. pneumoniae; Euroimmun, 
Lübeck, Germany) and Mycoplasma pneumoniae (Plate-
lia M. pneumoniae IgM; Bio-Rad, Hercules, CA, USA). 
For each patient, HAdV was the only pathogen detected 
in nasopharyngeal secretions collected at admission and 
in bronchoalveolar lavage fluids collected while in the 
intensive care unit (molecular multiplex assay [FilmAr-
ray Respiratory Panel; bioMérieux, Durham, NC, USA]). 
HAdV DNA was also detected in whole blood (Adeno-
virus R-gene; bioMérieux); viral load was 280,524 cop-
ies/mL for patient A 9 days after hospital admission and 
951,146 copies/mL for patient B 4 days after admission. 
During hospitalization, transient hepatitis developed in 
each patient; serum aspartate aminotransferase levels 
were elevated up to 6–10 times reference range, and leu-
kocyte counts indicated leukopenia (2.17 and 1.28 × 109/L 
for patients A and B, respectively; reference range 4–10 
× 109/L). Patient B had acute pancreatitis and hyperlipa-
semia (lipase 1,697 UI/L; reference range 73–393 UI/L). 
Healthy respiratory function was restored for both pa-
tients, who were discharged 26 (patient A) and 19 (patient 
B) days after admission.
A partial region of the hexon gene was amplified and 
sequenced from DNA extracts of respiratory and blood 
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Figure. Phylogeny of 13 complete-genome sequences of human adenovirus type 55 (A) and of 21 sequences of hexon genes (B). 
The complete genome tree (A) is rooted to a human adenovirus type 14 isolate (GenBank accession no. JX892927). The strains from 
patients A and B (immunocompetent women with human adenovirus infection) reported in this study are indicated. The phylogenetic tree 
was calculated by using the maximum-likelihood method in MEGA6 (http://www.megasoftware.net). The best algorithm was chosen by 
the criterion score of the Bayesian information criteria. The statistical robustness of branches was estimated by 1,000 bootstraps. Only 
bootstrap values >70% are indicated. The tree is drawn to scale; branch lengths are measured in number of substitutions per site (scale 
bar). All positions containing gaps and missing data were eliminated. The sequence of the hexon gene from patient B was partially 
complete (2,821/2,841, 99.3%).
samples, as previously described (6). Phylogenetic analy-
sis with strains representing all HAdV genotypes identified 
the viruses as HAdV-55 (data not shown). We performed 
complete-genome sequencing, which is now recommended 
for confirmation of HAdV type, by using next-generation 
sequencing from blood samples (online Technical Ap-
pendix, http://wwwnc.cdc.gov/EID/article/22/11/16-0728-
Techapp1.pdf). Genome coverage (34,755 nt) was 99.1% 
(patient A) and 96.1% (patient B). Phylogenetic analysis 
showed that the sequences of the isolates from the 2 pa-
tients clustered together (bootstrap 99%) and were geneti-
cally more closely related to the sequences of the CQ-814 
strain isolated in China in 2010 and the strain from Argen-
tina (GenBank accession no. JX423384) (Figure, panel 
A). To investigate genetic relationships with more strains 
from distant geographic areas, we performed phylogenetic 
analyses with all available sequences of the hexon gene of 
HAdV-55 strains. However, because diversity of this gene 
between strains was low, we could not determine the geo-
graphic origin of the strains from France, which were ge-
netically distant from the strain isolated in Spain in 1969 
(Figure, panel B).
Over the past 10 years, reports of HAdV-55 have been 
increasing in Asia during outbreaks of respiratory diseases 
that in some cases led to severe pneumonia and deaths in 
immunocompetent adults and children (2–4,7,8). Of the 
969 cases of community-acquired pneumonia in adults, 48 
(5%) were associated with HAdVs; HAdV-55 was identi-
fied in 21 (43.8%) of these patients (7). For the 2 patients 
we report, clinical features were similar to those described 
elsewhere (4,8). Neither patient had traveled recently, and 
the 2 patients had not had contact with each other. Analysis 
of complete genomic sequences showed that the viruses in-
fecting the patients were distinguishable from strains previ-
ously isolated in other countries. HAdV-55 could thus have 
been circulating in France for several years. Since its first 
detection in Spain in 1969 (9), HAdV-55 has been reported 
only 1 time in Europe, in Germany in 2004 (10). 
Because most HAdV infections are asymptomatic and 
respiratory virus screening in routine practice does not sys-
tematically include HAdV detection, the true prevalence 
and clinical effect of HAdV-55 infection has probably been 
underestimated. The involvement of virus of this genotype 
in severe pneumonia emphasizes the need to reinforce 
HAdV surveillance by including HAdV genome detection 
and genotyping (if positive) in the documentation of severe 
respiratory infections.
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